1
|
Roquefeuil L, Iskandar K, Roques C, Marchin L, Guittard M, Poupet H, Brandely-Piat ML, Jobard M. Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study. Pharmaceutics 2024; 16:933. [PMID: 39065630 PMCID: PMC11279954 DOI: 10.3390/pharmaceutics16070933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Revised: 07/08/2024] [Accepted: 07/09/2024] [Indexed: 07/28/2024] Open
Abstract
The microbial contamination of eye drop tips and caps varies between 7.7% and 100%. In seeking patient protection and continuous improvement, the Pharmacy Department in the Sterile Ophthalmological and Oncological Preparations Unit at Cochin Hospital AP-HP, Paris, France, conducted a two-phase study to compare the antimicrobial efficiency and practical use of standard packaging and a marketed eye drop container incorporating a self-decontaminating antimicrobial green technology by Pylote SAS at the tip and cap sites. The first phase was conducted in situ to identify the microbial contaminants of eye drops used in the hospital and community settings. A total of 110 eye drops were included for testing. Staphylococcus species were the most prevalent bacteria. Candida parapsilosis was detected in only one residual content sample and, at the same time, on the cap and tip. The second phase was performed in vitro, according to JIS Z2801. Reductions above one log in Staphylococcus aureus and Pseudomonas aeruginosa counts were noted in Pylote SAS eye drop packaging after 24 h of contact. The practical tests showed satisfactory results. Pylote SAS antimicrobial mineral oxide technology exhibited promising effects that combined effectiveness, safety, and sustainability to protect the patient by preventing infections due to the contamination of eye drop containers.
Collapse
Affiliation(s)
- Léa Roquefeuil
- Unité de Préparations Stériles Ophtalmologiques et Oncologiques, GHU AP-HP Centre-Université de Paris Cité—Site Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France; (L.R.); (M.-L.B.-P.); (M.J.)
| | - Katia Iskandar
- Department of Pharmacy, School of Pharmacy, Lebanese International University, Beirut 1105, Lebanon
- Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut 1103, Lebanon
| | - Christine Roques
- Laboratoire de Génie Chimique, CNRS, INPT, UPS, Faculté de Pharmacie, Université de Toulouse, 31062 Toulouse, France;
- FONDEREPHAR, Faculté de Pharmacie, 31062 Toulouse, France
| | - Loïc Marchin
- Pylote SAS, 22 Avenue de la Mouyssaguèse, 31280 Drémil-Lafage, France; (L.M.); (M.G.)
| | - Mylène Guittard
- Pylote SAS, 22 Avenue de la Mouyssaguèse, 31280 Drémil-Lafage, France; (L.M.); (M.G.)
| | - Hélène Poupet
- Laboratoire de Bactériologie, GHU AP-HP Centre-Université de Paris Cité—Site Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France;
| | - Marie-Laure Brandely-Piat
- Unité de Préparations Stériles Ophtalmologiques et Oncologiques, GHU AP-HP Centre-Université de Paris Cité—Site Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France; (L.R.); (M.-L.B.-P.); (M.J.)
| | - Marion Jobard
- Unité de Préparations Stériles Ophtalmologiques et Oncologiques, GHU AP-HP Centre-Université de Paris Cité—Site Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France; (L.R.); (M.-L.B.-P.); (M.J.)
| |
Collapse
|
2
|
Iskandar K, Pecastaings S, LeGac C, Salvatico S, Feuillolay C, Guittard M, Marchin L, Verelst M, Roques C. Demonstrating the In Vitro and In Situ Antimicrobial Activity of Oxide Mineral Microspheres: An Innovative Technology to Be Incorporated into Porous and Nonporous Materials. Pharmaceutics 2023; 15:pharmaceutics15041261. [PMID: 37111747 PMCID: PMC10144421 DOI: 10.3390/pharmaceutics15041261] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Revised: 03/26/2023] [Accepted: 04/07/2023] [Indexed: 04/29/2023] Open
Abstract
The antimicrobial activity of surfaces treated with zinc and/or magnesium mineral oxide microspheres is a patented technology that has been demonstrated in vitro against bacteria and viruses. This study aims to evaluate the efficiency and sustainability of the technology in vitro, under simulation-of-use conditions, and in situ. The tests were undertaken in vitro according to the ISO 22196:2011, ISO 20473:2013, and NF S90-700:2019 standards with adapted parameters. Simulation-of-use tests evaluated the robustness of the activity under worst-case scenarios. The in situ tests were conducted on high-touch surfaces. The in vitro results show efficient antimicrobial activity against referenced strains with a log reduction of >2. The sustainability of this effect was time-dependent and detected at lower temperatures (20 ± 2.5 °C) and humidity (46%) conditions for variable inoculum concentrations and contact times. The simulation of use proved the microsphere's efficiency under harsh mechanical and chemical tests. The in situ studies showed a higher than 90% reduction in CFU/25 cm2 per treated surface versus the untreated surfaces, reaching a targeted value of <50 CFU/cm2. Mineral oxide microspheres can be incorporated into unlimited surface types, including medical devices, to efficiently and sustainably prevent microbial contamination.
Collapse
Affiliation(s)
- Katia Iskandar
- Department of Pharmacy, School of Pharmacy, Lebanese International University, Bekaa P.O. Box 146404, Lebanon
- National Institute of Public Health, Clinical Epidemiology, and Toxicology-Lebanon (INSPECT-LB), Beirut 6573, Lebanon
| | - Sophie Pecastaings
- Laboratoire de Génie Chimique, Faculté de Pharmacie, Université de Toulouse, CNRS, INPT, UPS, 31062 Toulouse, France
| | - Céline LeGac
- FONDEREPHAR, Faculté de Pharmacie, 31062 Toulouse, France
| | | | | | - Mylène Guittard
- Pylote SAS, 22 Avenue de la Mouyssaguèse, 31280 Drémil-Lafage, France
| | - Loïc Marchin
- Pylote SAS, 22 Avenue de la Mouyssaguèse, 31280 Drémil-Lafage, France
| | - Marc Verelst
- CEMES, UPR CNRS 8011, 29 Rue Jeanne Marvig, CEDEX, 31055 Toulouse, France
| | - Christine Roques
- Laboratoire de Génie Chimique, Faculté de Pharmacie, Université de Toulouse, CNRS, INPT, UPS, 31062 Toulouse, France
- FONDEREPHAR, Faculté de Pharmacie, 31062 Toulouse, France
| |
Collapse
|
3
|
Peters A, Parneix P, Kiernan M, Severin JA, Gauci T, Pittet D. New frontiers in healthcare environmental hygiene: thoughts from the 2022 healthcare cleaning forum. Antimicrob Resist Infect Control 2023; 12:7. [PMID: 36750872 PMCID: PMC9902814 DOI: 10.1186/s13756-022-01185-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 11/11/2022] [Indexed: 02/09/2023] Open
Abstract
Healthcare environmental hygiene (HEH) has become recognized as being increasingly important for patient safety and the prevention of healthcare-associated infections. At the 2022 Healthcare Cleaning Forum at Interclean in Amsterdam, the academic lectures focused on a series of main areas of interest. These areas are indicative of some of the main trends and avenues for research in the coming years. Both industry and academia need to take steps to continue the momentum of HEH as we transition out of the acute phase of the Covid-19 pandemic. There is a need for new ways to facilitate collaboration between the academic and private sectors. The Clean Hospitals® network was presented in the context of the need for both cross-disciplinarity and evidence-based interventions in HEH. Governmental bodies have also become more involved in the field, and both the German DIN 13603 standard and the UK NHS Cleaning Standards were analyzed and compared. The challenge of environmental pathogens was explored through the example of how P. aeruginosa persists in the healthcare environment. New innovations in HEH were presented, from digitalization to tracking, and automated disinfection to antimicrobial surfaces. The need for sustainability in HEH was also explored, focusing on the burden of waste, the need for a circular economy, and trends towards increasingly local provision of goods and services. The continued focus on and expansion of these areas of HEH will result in safer patient care and contribute to better health systems.
Collapse
Affiliation(s)
- Alexandra Peters
- Infection Control Programme and WHO Collaborating Center On Infection Prevention and Control and Antimicrobial Resistance, Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Pierre Parneix
- Nouvelle Aquitaine Health Care-Associated Infection Control Centre, Bordeaux University Hospital, Bordeaux, France
| | - Martin Kiernan
- Richard Wells Research Centre, University of West London, London, UK
| | - Juliëtte A Severin
- Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
| | - Tracey Gauci
- Hywel Dda University Health Board, NHS Wales, Carmarthen, UK
| | - Didier Pittet
- Infection Control Programme and WHO Collaborating Center On Infection Prevention and Control and Antimicrobial Resistance, Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
| |
Collapse
|
4
|
Iskandar K, Marchin L, Kodjikian L, Rocher M, Roques C. Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review. Pharmaceutics 2022; 14:2176. [PMID: 36297611 PMCID: PMC9611205 DOI: 10.3390/pharmaceutics14102176] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 09/29/2022] [Accepted: 10/05/2022] [Indexed: 11/16/2022] Open
Abstract
The sterility of eye drop content is a primary concern from manufacturing until opening, as well as during handling by end users, while microbial contamination of the dropper tip and cap are often disregarded. The contamination of these sites during drug administration represents a risk of microbial transmission and ocular infection. In this review, we aim to assess microbial contamination of the dropper tip and cap of in-use eye drops, the associated contributory factors, and the risk of infection. We conducted a literature search of the MEDLINE, PubMed, and Cochrane Central databases. A total of 31 out of 1503 studies were selected. All the studies conducted in different settings that documented microbiologically contaminated in-use eye drops were included. Our review showed that microbial contamination of the dropper tip and cap of in-use eye drops ranged from 7.7 to 100% of the total contaminated tested samples. Documented contributory factors were conflicting across the literature. Studies investigating the association between eye infection and microbial contamination of the dropper tip and cap were scarce. New technologies offer a promising potential for securing the long-term sterility of eye drop content, tips, and caps, which could benefit from more research and well-defined study protocols under real-life scenarios.
Collapse
Affiliation(s)
- Katia Iskandar
- Département des Sciences Pharmaceutiques, Faculté de Pharmacie, Université Libanaise, Beirut 1500, Lebanon
- INSPECT-LB—Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban, Beirut 1202, Lebanon
| | - Loïc Marchin
- Pylote SAS, 22 Avenue de la Mouyssaguèse, Dremil-Lafage, 31280 Toulouse, France
| | - Laurent Kodjikian
- Service d’Ophtalmologie, CHU de la Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France
- Département d’Ophtalmologie, Université de Lyon 1, UMR-CNRS 5510, Matéis, INSA, Villeurbanne, 69100 Lyon, France
| | - Maxime Rocher
- Department of Ophthalmology, Limoges University Hospital, 87000 Limoges, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire Limoges, Université de Limoges, RESINFIT, 87000 Limoges, France
| | - Christine Roques
- Laboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Faculté de Pharmacie, 31062 Toulouse, France
- FONDEREPHAR, Faculté de Pharmacie, 31062 Toulouse, France
| |
Collapse
|
5
|
Singh J, Hegde PB, Ravindra P, Sen P, Avasthi S. Ambient Light-Activated Antibacterial Material: Manganese Vanadium Oxide (Mn 2V 2O 7). ACS APPLIED BIO MATERIALS 2021; 4:6903-6911. [DOI: 10.1021/acsabm.1c00605] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Jagriti Singh
- Centre for Nanoscience and Engineering, Indian Institute of Science, Bengaluru 560012, India
| | - Prajwal B. Hegde
- Centre for Nanoscience and Engineering, Indian Institute of Science, Bengaluru 560012, India
| | - Pramod Ravindra
- Centre for Nanoscience and Engineering, Indian Institute of Science, Bengaluru 560012, India
| | - Prosenjit Sen
- Centre for Nanoscience and Engineering, Indian Institute of Science, Bengaluru 560012, India
| | - Sushobhan Avasthi
- Centre for Nanoscience and Engineering, Indian Institute of Science, Bengaluru 560012, India
| |
Collapse
|